EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy

Lei Meng, Fangshu Liu, Chenchen Du, Jiaying Zhu, Qian Xiong, Jing Li, Weitong Sun iD

Molecules · 2023

DOI: 10.3390/molecules28093824 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Lei Meng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Jiamusi University, Jiamusi 154007, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North Medicine and Functional Food Characteristic Subject Project in Heilongjiang Province, Natural Science Foundation of Heilongjiang Province of China, Heilongjiang Postdoctoral Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this work, glucose transporter-1 (GLUT-1) and glutathione (GSH) over-expression in liver cancer was utilized to design a reduction-responsive and active targeting drug delivery system AG-PEG-SS-PCL (APSP) for the delivery of sorafenib (SF). The SF-APSP micelles were prepared using the thin film hydration method and characterized by various techniques. In vitro release experiments showed that the cumulative release of SF-APSP micelles in the simulated tumor microenvironment (pH 7.4 with GSH) reached 94.76 ± 1.78% at 48 h, while it was only 20.32 ± 1.67% in the normal physiological environment (pH 7.4 without GSH). The in vitro study revealed that glucosamine (AG) enhanced the antitumor effects of SF, and SF-APSP micelles inhibited proliferation by targeting HepG2 cells and suppressing cyclin D1 expression. The in vivo antitumor efficacy study further confirmed that the SF-APSP micelles had excellent antitumor effects and better tolerance against nude mouse with HepG2 cells than other treatment groups. All in all, these results indicated that SF-APSP micelles could be a promising drug delivery system for anti-hepatoma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularMiceAnimalsMicellesDrug Delivery SystemsPolymersSorafenibHydrogen-Ion ConcentrationDoxorubicinDrug CarriersTumor MicroenvironmentPolyethylene GlycolsSuccinimides

Stichwörter der Autor:innen

glucosamineliver cancerpolymer micellesreduction-responsivesorafenib

Substanzen

MicellesPolymersSorafenibDoxorubicinDrug Carrierspolyethylene glycol bis(succinimidyl succinate)Polyethylene GlycolsSuccinimides

Autor:innen und Institutionen

  • College of Pharmacy, Jiamusi University, Jiamusi 154007, China.

ORCID-Profile: Weitong Sun

Förderung

  • North Medicine and Functional Food Characteristic Subject Project in Heilongjiang Province
  • Natural Science Foundation of Heilongjiang Province of China
  • Heilongjiang Postdoctoral Foundation
  • Provincial Undergraduate Colleges Basal Research Foundation
  • Doctoral Scientific Research Startup Fund
  • Heilongjiang Provincial Key Laboratory of New Drug Development and Pharmacotoxicological Evaluation
  • College Students’ Innovation and Entrepreneurship Training Program

Zitieren

APA

Meng, L., Liu, F., Du, C., Zhu, J., Xiong, Q., Li, J., & Sun, W. (2023). Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy. Molecules. https://doi.org/10.3390/molecules28093824

Vancouver

Meng L, Liu F, Du C, Zhu J, Xiong Q, Li J, et al. Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy. Molecules. 2023. doi:10.3390/molecules28093824

BibTeX
@article{Meng2023,
  author = {Meng, Lei and Liu, Fangshu and Du, Chenchen and Zhu, Jiaying and Xiong, Qian and Li, Jing and Sun, Weitong},
  title = {Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28093824}
}
Kostenlos starten →